Comparative Grey and White Matter Tau Pathology in LBD and PSP using Digital Histologic Measurements
Objective: To compare the regional distribution of cortical tau pathology between Lewy body disorders (LBD: Parkinson’s disease and dementia with Lewy bodies (DLB)) and progressive…Neuroanatomical and clinical predictors of pain in patients with early de novo Parkinson’s disease
Objective: We investigated associations between clinical features, neuroanatomical changes and pain in early de novo Parkinson’s disease (PD) patients. Background: Pain is a common and…Role of microRNA-153 and -223 in Parkinson disease
Objective: To assess the therapeutic and diagnostic potential of microRNA (miR)-153 and miR-223 in mice and humans with parkinsonism. Background: Dysregulated miRNAs play a major…Attentional Intervention to Improve Cognition and Gait in Parkinson’s Disease: Side of Onset Effects
Objective: To establish whether home-based computerized attentional training would improve cognition, gait, and function in Parkinson’s disease (PD). Background: Impairments in cognition and gait are…Nutritional status in patients with Parkinson’s disease and its relationship with the motor phenotype.
Objective: To determine the nutritional status in patients with Parkinson's disease and to relate it to the motor phenotype. Background: Parkinson disease (PD) is a…Dry eye in Parkinson’s disease: symptoms, consequences and treatment options
Objective: Dry eye is a common side effect of PD/PSP and easily manageable, yet its occurrence and debilitating ramifications are often unrecognized. The aim of…Cerebellar transcranial magnetic stimulation with neuronavigation for postural instability in PSP
Objective: We created a TMS protocol for paired-pulse cerebellar-M1 stimulation and repetitive cerebellar stimulation to augment cerebellar-brain inhibition and reduce postural instability in progressive supranuclear…Bumetanide to treat Parkinson’s disease patients suffering from freezing of gait resistant to both dopamine replacement treatment and subthalamic deep brain stimulation: an open-label pilot study (BumFOG)
Objective: to investigate the effects of bumetanide in Parkinson's disease (PD) patients suffering from freezing of gait (FOG) resistant to dopamine replacement therapy and subthalamic…The impact of medication and deep brain stimulation on visuo-motor coordination in Parkinson’s disease
Objective: The results presented herein are part of a larger study looking at the impact of medication and deep brain stimulation (DBS) on voluntary and…Beyond the Periphery: Central Auditory Processing in Parkinsonian Disorders
Objective: This systematic review provides an overview of behavioral and event-related potential (ERP) studies investigating central auditory processing in patients with Parkinson’s disease (PD), progressive…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.